Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18

Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study

Total article views   HTML views PDF downloads Totals
3,395 Dovepress* 3,246+ 63 3,309
PubMed Central* 149 137 286
Totals 3,395 200 3,595
*Since 2 November 2022

View citations on PubMed Central and Google Scholar